Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.53932717 |
2 | modulation by symbiont of host immune response (GO:0052553) | 5.53932717 |
3 | positive regulation by symbiont of host defense response (GO:0052509) | 5.53932717 |
4 | modulation by symbiont of host defense response (GO:0052031) | 5.53932717 |
5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.53932717 |
6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.53932717 |
7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.02399850 |
8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.99258899 |
9 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.47856738 |
10 | macrophage activation involved in immune response (GO:0002281) | 4.29860139 |
11 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.11741874 |
12 | detection of other organism (GO:0098543) | 4.07186755 |
13 | negative regulation of interleukin-12 production (GO:0032695) | 3.92309137 |
14 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.85050077 |
15 | response to host immune response (GO:0052572) | 3.85050077 |
16 | microglial cell activation (GO:0001774) | 3.83558450 |
17 | regulation of gamma-delta T cell activation (GO:0046643) | 3.75727150 |
18 | detection of external biotic stimulus (GO:0098581) | 3.73373949 |
19 | detection of bacterium (GO:0016045) | 3.63741313 |
20 | neutrophil activation involved in immune response (GO:0002283) | 3.60631013 |
21 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.59567908 |
22 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.56524718 |
23 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.56053140 |
24 | response to host (GO:0075136) | 3.56053140 |
25 | response to host defenses (GO:0052200) | 3.56053140 |
26 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.54922909 |
27 | positive regulation of interferon-alpha production (GO:0032727) | 3.49472436 |
28 | germinal center formation (GO:0002467) | 3.42139126 |
29 | detection of biotic stimulus (GO:0009595) | 3.37010767 |
30 | response to peptidoglycan (GO:0032494) | 3.32476837 |
31 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.31480608 |
32 | regulation of interferon-alpha production (GO:0032647) | 3.28999894 |
33 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.28864291 |
34 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.17090543 |
35 | negative regulation of granulocyte differentiation (GO:0030853) | 3.16851295 |
36 | immunoglobulin mediated immune response (GO:0016064) | 3.16222539 |
37 | macrophage activation (GO:0042116) | 3.12850407 |
38 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.11039071 |
39 | respiratory burst (GO:0045730) | 3.10539848 |
40 | * regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.06033370 |
41 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.05232784 |
42 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.02407104 |
43 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.00549996 |
44 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.94648334 |
45 | leukocyte aggregation (GO:0070486) | 2.91978300 |
46 | cellular extravasation (GO:0045123) | 2.91896927 |
47 | positive regulation of macrophage cytokine production (GO:0060907) | 2.89834672 |
48 | myeloid cell activation involved in immune response (GO:0002275) | 2.86377187 |
49 | apoptotic cell clearance (GO:0043277) | 2.83258633 |
50 | B cell receptor signaling pathway (GO:0050853) | 2.81652908 |
51 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.81221940 |
52 | response to muramyl dipeptide (GO:0032495) | 2.79312909 |
53 | cell adhesion mediated by integrin (GO:0033627) | 2.78028180 |
54 | granulocyte activation (GO:0036230) | 2.77408696 |
55 | * regulation of regulated secretory pathway (GO:1903305) | 2.77197555 |
56 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.76706474 |
57 | detection of molecule of bacterial origin (GO:0032490) | 2.75071617 |
58 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.74883302 |
59 | I-kappaB phosphorylation (GO:0007252) | 2.74577520 |
60 | negative regulation of T cell mediated immunity (GO:0002710) | 2.73694120 |
61 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.73290724 |
62 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.73029314 |
63 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.72310782 |
64 | regulation of macrophage cytokine production (GO:0010935) | 2.71700433 |
65 | neutrophil mediated immunity (GO:0002446) | 2.69709122 |
66 | mannose metabolic process (GO:0006013) | 2.67151248 |
67 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.66605349 |
68 | myeloid leukocyte mediated immunity (GO:0002444) | 2.66347720 |
69 | positive regulation of antigen processing and presentation (GO:0002579) | 2.66218585 |
70 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.65748980 |
71 | cellular response to interferon-alpha (GO:0035457) | 2.64903644 |
72 | defense response to protozoan (GO:0042832) | 2.64899287 |
73 | negative regulation of type 2 immune response (GO:0002829) | 2.63395047 |
74 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.63007177 |
75 | neutrophil activation (GO:0042119) | 2.62613606 |
76 | regulation of mononuclear cell migration (GO:0071675) | 2.58926703 |
77 | regulation of cholesterol storage (GO:0010885) | 2.57258187 |
78 | glomerular visceral epithelial cell development (GO:0072015) | 2.56324712 |
79 | positive regulation of p38MAPK cascade (GO:1900745) | 2.55426699 |
80 | positive regulation of Rap GTPase activity (GO:0032854) | 2.53797036 |
81 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.53680814 |
82 | leukocyte degranulation (GO:0043299) | 2.53117076 |
83 | positive regulation of type 2 immune response (GO:0002830) | 2.52251063 |
84 | response to interleukin-15 (GO:0070672) | 2.52193038 |
85 | regulation of tolerance induction (GO:0002643) | 2.50550750 |
86 | positive regulation of heat generation (GO:0031652) | 2.49407421 |
87 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.48334099 |
88 | response to protozoan (GO:0001562) | 2.48251749 |
89 | regulation of type 2 immune response (GO:0002828) | 2.48108361 |
90 | * regulation of mast cell degranulation (GO:0043304) | 2.46562925 |
91 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.45616000 |
92 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.44470117 |
93 | regulation of ARF protein signal transduction (GO:0032012) | 2.43655702 |
94 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.42956985 |
95 | negative regulation of interleukin-6 production (GO:0032715) | 2.42952134 |
96 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.42631900 |
97 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.41032912 |
98 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.41030773 |
99 | T-helper 1 type immune response (GO:0042088) | 2.40957329 |
100 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.39584549 |
101 | response to interferon-alpha (GO:0035455) | 2.39063081 |
102 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.38563987 |
103 | negative regulation of cell killing (GO:0031342) | 2.38563987 |
104 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.38265698 |
105 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.38139803 |
106 | regulation of T cell tolerance induction (GO:0002664) | 2.37352804 |
107 | neutrophil chemotaxis (GO:0030593) | 2.37060596 |
108 | * positive regulation of mast cell activation (GO:0033005) | 2.36683127 |
109 | * regulation of mast cell activation involved in immune response (GO:0033006) | 2.36236215 |
110 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.36122918 |
111 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.35337840 |
112 | * regulation of leukocyte degranulation (GO:0043300) | 2.34022994 |
113 | cellular response to type I interferon (GO:0071357) | 2.33686224 |
114 | type I interferon signaling pathway (GO:0060337) | 2.33686224 |
115 | response to type I interferon (GO:0034340) | 2.33365842 |
116 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.31951287 |
117 | * positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.31927495 |
118 | * positive regulation of mast cell degranulation (GO:0043306) | 2.31927495 |
119 | positive regulation of B cell differentiation (GO:0045579) | 2.31430239 |
120 | neutrophil migration (GO:1990266) | 2.30918537 |
121 | positive regulation of interferon-beta production (GO:0032728) | 2.30711729 |
122 | glomerular epithelial cell development (GO:0072310) | 2.30700248 |
123 | regulation of integrin activation (GO:0033623) | 2.30557776 |
124 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.29406791 |
125 | wound healing, spreading of epidermal cells (GO:0035313) | 2.28452398 |
126 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.27957327 |
127 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.27659594 |
128 | fibroblast migration (GO:0010761) | 2.26928626 |
129 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.25099678 |
130 | germ cell migration (GO:0008354) | 2.23927523 |
131 | myeloid leukocyte activation (GO:0002274) | 2.23889122 |
132 | * regulation of mast cell activation (GO:0033003) | 2.23685522 |
133 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.22735855 |
134 | histamine secretion (GO:0001821) | 2.22539355 |
135 | negative regulation of interleukin-17 production (GO:0032700) | 2.21940132 |
136 | monocyte chemotaxis (GO:0002548) | 2.19760654 |
137 | clathrin coat assembly (GO:0048268) | 2.16416281 |
138 | regulation of macrophage chemotaxis (GO:0010758) | 2.15570188 |
139 | regulation of p38MAPK cascade (GO:1900744) | 2.15278392 |
140 | cytokine secretion (GO:0050663) | 2.14815010 |
141 | glomerular basement membrane development (GO:0032836) | 2.14415874 |
142 | pinocytosis (GO:0006907) | 2.13758681 |
143 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.13623325 |
144 | phagocytosis, engulfment (GO:0006911) | 2.12147050 |
145 | granulocyte chemotaxis (GO:0071621) | 2.12041559 |
146 | negative regulation of mast cell activation (GO:0033004) | 2.11686063 |
147 | negative regulation of macrophage differentiation (GO:0045650) | 2.11111598 |
148 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.10821926 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.66204503 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.03144690 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.48283024 |
4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.17398366 |
5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.13424067 |
6 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.02519083 |
7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.88901047 |
8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.80718055 |
9 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.69470902 |
10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.66886849 |
11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.41606070 |
12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.37100745 |
13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.35488344 |
14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.27802179 |
15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.07828306 |
16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.06804945 |
17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.01505334 |
18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.99020640 |
19 | SPI1_23127762_ChIP-Seq_K562_Human | 1.97244744 |
20 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.96250094 |
21 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.91677546 |
22 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.88872923 |
23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.87582759 |
24 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.70885914 |
25 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.69361404 |
26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.66372025 |
27 | MYC_22102868_ChIP-Seq_BL_Human | 1.66334193 |
28 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.64185396 |
29 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.63885784 |
30 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.59058792 |
31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54794521 |
32 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.52546429 |
33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.51659646 |
34 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.51262047 |
35 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.50447010 |
36 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.48564246 |
37 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.46664270 |
38 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.45547042 |
39 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.45030978 |
40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.43359179 |
41 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.43230738 |
42 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.42152380 |
43 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.37843680 |
44 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.33572073 |
45 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.30064358 |
46 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.29832309 |
47 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.27128260 |
48 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.25095810 |
49 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.23149314 |
50 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.20675032 |
51 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.20672640 |
52 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.19758066 |
53 | KDM2B_26808549_Chip-Seq_K562_Human | 1.17445987 |
54 | MYB_26560356_Chip-Seq_TH1_Human | 1.17336164 |
55 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.16825253 |
56 | CJUN_26792858_Chip-Seq_BT549_Human | 1.14128255 |
57 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.12740383 |
58 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12290504 |
59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.12194378 |
60 | MAF_26560356_Chip-Seq_TH2_Human | 1.12121159 |
61 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.10382907 |
62 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10186869 |
63 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10116016 |
64 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.09733828 |
65 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.08931648 |
66 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.07579768 |
67 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06982187 |
68 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.04199167 |
69 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.03657861 |
70 | GATA2_19941826_ChIP-Seq_K562_Human | 1.03637618 |
71 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03515120 |
72 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.03398421 |
73 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03215581 |
74 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03051085 |
75 | MAF_26560356_Chip-Seq_TH1_Human | 1.03018076 |
76 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.01984766 |
77 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.01285096 |
78 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.01097255 |
79 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00965629 |
80 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00863236 |
81 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99614375 |
82 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.99470043 |
83 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98865051 |
84 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.97730652 |
85 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.97596931 |
86 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97146435 |
87 | MYB_26560356_Chip-Seq_TH2_Human | 0.95795774 |
88 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95438108 |
89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95402435 |
90 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.94675913 |
91 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.94207723 |
92 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.93461168 |
93 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.93320210 |
94 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.93253083 |
95 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92249036 |
96 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.92191571 |
97 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.92141523 |
98 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.92075895 |
99 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92015248 |
100 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91127993 |
101 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.91126844 |
102 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.91126844 |
103 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.91053996 |
104 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.91053996 |
105 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.90536476 |
106 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.89237990 |
107 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89178269 |
108 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.89122210 |
109 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.88872733 |
110 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.88708310 |
111 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.88673080 |
112 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.86947220 |
113 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86786803 |
114 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86669432 |
115 | GATA1_22025678_ChIP-Seq_K562_Human | 0.84974478 |
116 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.84771014 |
117 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.84470138 |
118 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.84178540 |
119 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.84129712 |
120 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.84121849 |
121 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.83586158 |
122 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.83174007 |
123 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.82984765 |
124 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82660707 |
125 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.82113179 |
126 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.80312632 |
127 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.80136273 |
128 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80083752 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0000569_abnormal_digit_pigmentation | 4.44255577 |
2 | MP0003303_peritoneal_inflammation | 3.47550776 |
3 | MP0008438_abnormal_cutaneous_collagen | 2.88272569 |
4 | MP0009278_abnormal_bone_marrow | 2.73104618 |
5 | MP0004510_myositis | 2.69097937 |
6 | MP0001835_abnormal_antigen_presentation | 2.66036234 |
7 | MP0005058_abnormal_lysosome_morphology | 2.64144598 |
8 | MP0003436_decreased_susceptibility_to | 2.58066799 |
9 | MP0002419_abnormal_innate_immunity | 2.39334055 |
10 | MP0003183_abnormal_peptide_metabolism | 2.33508594 |
11 | MP0003172_abnormal_lysosome_physiology | 2.30364620 |
12 | MP0005451_abnormal_body_composition | 2.20343906 |
13 | MP0003724_increased_susceptibility_to | 2.16594081 |
14 | * MP0002148_abnormal_hypersensitivity_rea | 2.13360154 |
15 | MP0003300_gastrointestinal_ulcer | 2.07764062 |
16 | MP0005167_abnormal_blood-brain_barrier | 2.03875850 |
17 | MP0006082_CNS_inflammation | 2.03639994 |
18 | MP0001958_emphysema | 1.99901134 |
19 | MP0005000_abnormal_immune_tolerance | 1.97124277 |
20 | MP0003828_pulmonary_edema | 1.94085080 |
21 | MP0001533_abnormal_skeleton_physiology | 1.89532307 |
22 | MP0009785_altered_susceptibility_to | 1.89477340 |
23 | MP0000343_altered_response_to | 1.85447496 |
24 | MP0008260_abnormal_autophagy | 1.84239011 |
25 | MP0005464_abnormal_platelet_physiology | 1.83286348 |
26 | * MP0005025_abnormal_response_to | 1.76510700 |
27 | MP0008004_abnormal_stomach_pH | 1.74360617 |
28 | MP0002452_abnormal_antigen_presenting | 1.68619443 |
29 | MP0003448_altered_tumor_morphology | 1.60560786 |
30 | MP0001879_abnormal_lymphatic_vessel | 1.58779224 |
31 | MP0003566_abnormal_cell_adhesion | 1.51596092 |
32 | MP0005397_hematopoietic_system_phenotyp | 1.51324430 |
33 | MP0001545_abnormal_hematopoietic_system | 1.51324430 |
34 | MP0003329_amyloid_beta_deposits | 1.49616764 |
35 | MP0002723_abnormal_immune_serum | 1.47800788 |
36 | MP0005387_immune_system_phenotype | 1.47779348 |
37 | MP0001790_abnormal_immune_system | 1.47779348 |
38 | * MP0002998_abnormal_bone_remodeling | 1.45577901 |
39 | MP0004130_abnormal_muscle_cell | 1.45244240 |
40 | MP0002166_altered_tumor_susceptibility | 1.44906146 |
41 | MP0003191_abnormal_cellular_cholesterol | 1.44332563 |
42 | MP0005671_abnormal_response_to | 1.42463177 |
43 | MP0004858_abnormal_nervous_system | 1.39839367 |
44 | MP0002006_tumorigenesis | 1.39814652 |
45 | MP0003091_abnormal_cell_migration | 1.38609047 |
46 | * MP0001819_abnormal_immune_cell | 1.38387822 |
47 | MP0004084_abnormal_cardiac_muscle | 1.35434263 |
48 | MP0008961_abnormal_basal_metabolism | 1.34767804 |
49 | * MP0002420_abnormal_adaptive_immunity | 1.34219487 |
50 | MP0003075_altered_response_to | 1.31319956 |
51 | MP0001800_abnormal_humoral_immune | 1.29409856 |
52 | MP0005409_darkened_coat_color | 1.29026165 |
53 | MP0005275_abnormal_skin_tensile | 1.28970753 |
54 | MP0003045_fibrosis | 1.27009526 |
55 | MP0005076_abnormal_cell_differentiation | 1.26869857 |
56 | MP0000767_abnormal_smooth_muscle | 1.26011410 |
57 | MP0005174_abnormal_tail_pigmentation | 1.22295528 |
58 | MP0003690_abnormal_glial_cell | 1.20276612 |
59 | MP0008775_abnormal_heart_ventricle | 1.19250306 |
60 | MP0005257_abnormal_intraocular_pressure | 1.19243226 |
61 | MP0003279_aneurysm | 1.18682316 |
62 | MP0000685_abnormal_immune_system | 1.16754815 |
63 | MP0001845_abnormal_inflammatory_respons | 1.16192006 |
64 | MP0004808_abnormal_hematopoietic_stem | 1.15327265 |
65 | MP0000920_abnormal_myelination | 1.13988980 |
66 | MP0004381_abnormal_hair_follicle | 1.13378821 |
67 | MP0010386_abnormal_urinary_bladder | 1.13104936 |
68 | MP0000751_myopathy | 1.12951968 |
69 | MP0004947_skin_inflammation | 1.11639300 |
70 | MP0002722_abnormal_immune_system | 1.11434842 |
71 | MP0009764_decreased_sensitivity_to | 1.11172889 |
72 | MP0005164_abnormal_response_to | 1.11120339 |
73 | MP0002132_abnormal_respiratory_system | 1.11037651 |
74 | MP0010368_abnormal_lymphatic_system | 1.09701329 |
75 | MP0005166_decreased_susceptibility_to | 1.09044551 |
76 | * MP0002429_abnormal_blood_cell | 1.07510559 |
77 | MP0000689_abnormal_spleen_morphology | 1.06770017 |
78 | MP0003763_abnormal_thymus_physiology | 1.06542028 |
79 | MP0005310_abnormal_salivary_gland | 1.06483818 |
80 | MP0009115_abnormal_fat_cell | 1.06020528 |
81 | MP0002405_respiratory_system_inflammati | 1.05967837 |
82 | MP0000604_amyloidosis | 1.05133727 |
83 | MP0009840_abnormal_foam_cell | 1.03444976 |
84 | MP0005390_skeleton_phenotype | 1.02156969 |
85 | MP0003705_abnormal_hypodermis_morpholog | 1.01970242 |
86 | MP0004883_abnormal_blood_vessel | 1.01460544 |
87 | MP0000249_abnormal_blood_vessel | 0.98901138 |
88 | MP0003646_muscle_fatigue | 0.97041934 |
89 | MP0005666_abnormal_adipose_tissue | 0.95996544 |
90 | MP0000703_abnormal_thymus_morphology | 0.95513824 |
91 | MP0005503_abnormal_tendon_morphology | 0.95416653 |
92 | MP0003866_abnormal_defecation | 0.95326154 |
93 | MP0004272_abnormal_basement_membrane | 0.94760649 |
94 | MP0008469_abnormal_protein_level | 0.91470981 |
95 | MP0001851_eye_inflammation | 0.90290033 |
96 | MP0005197_abnormal_uvea_morphology | 0.90214551 |
97 | MP0005623_abnormal_meninges_morphology | 0.86967572 |
98 | MP0002972_abnormal_cardiac_muscle | 0.86716947 |
99 | * MP0000716_abnormal_immune_system | 0.86590805 |
100 | MP0002837_dystrophic_cardiac_calcinosis | 0.86424157 |
101 | MP0000733_abnormal_muscle_development | 0.86292545 |
102 | MP0003879_abnormal_hair_cell | 0.85041475 |
103 | * MP0002398_abnormal_bone_marrow | 0.81970061 |
104 | MP0002933_joint_inflammation | 0.81887585 |
105 | MP0004859_abnormal_synaptic_plasticity | 0.81887374 |
106 | MP0002396_abnormal_hematopoietic_system | 0.81533327 |
107 | MP0009333_abnormal_splenocyte_physiolog | 0.80086880 |
108 | MP0008874_decreased_physiological_sensi | 0.79704163 |
109 | MP0000465_gastrointestinal_hemorrhage | 0.79624107 |
110 | MP0000015_abnormal_ear_pigmentation | 0.79392548 |
111 | MP0003656_abnormal_erythrocyte_physiolo | 0.78740082 |
112 | MP0002090_abnormal_vision | 0.77533206 |
113 | MP0010307_abnormal_tumor_latency | 0.76413390 |
114 | MP0000371_diluted_coat_color | 0.76169741 |
115 | MP0003453_abnormal_keratinocyte_physiol | 0.74914212 |
116 | MP0005535_abnormal_body_temperature | 0.74134534 |
117 | MP0002332_abnormal_exercise_endurance | 0.73392432 |
118 | MP0004484_altered_response_of | 0.73373807 |
119 | MP0010630_abnormal_cardiac_muscle | 0.73337567 |
120 | MP0001544_abnormal_cardiovascular_syste | 0.73026549 |
121 | MP0005385_cardiovascular_system_phenoty | 0.73026549 |
122 | MP0000858_altered_metastatic_potential | 0.72885751 |
123 | MP0001853_heart_inflammation | 0.71798135 |
124 | MP0010155_abnormal_intestine_physiology | 0.71522456 |
125 | MP0002295_abnormal_pulmonary_circulatio | 0.69404281 |
126 | MP0002009_preneoplasia | 0.68693955 |
127 | MP0009765_abnormal_xenobiotic_induced | 0.66649776 |
128 | MP0001501_abnormal_sleep_pattern | 0.66429985 |
129 | MP0003632_abnormal_nervous_system | 0.61058109 |
130 | MP0005334_abnormal_fat_pad | 0.60823734 |
131 | MP0002877_abnormal_melanocyte_morpholog | 0.60769883 |
132 | MP0001915_intracranial_hemorrhage | 0.60629280 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 5.10757217 |
2 | Recurrent bacterial skin infections (HP:0005406) | 4.77988771 |
3 | Increased cerebral lipofuscin (HP:0011813) | 4.51876344 |
4 | Eczematoid dermatitis (HP:0000976) | 4.47802588 |
5 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.79179479 |
6 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.78712420 |
7 | Abnormality of glycolipid metabolism (HP:0010969) | 3.78531009 |
8 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.78531009 |
9 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.78531009 |
10 | Systemic lupus erythematosus (HP:0002725) | 3.73919589 |
11 | Stomatitis (HP:0010280) | 3.59829593 |
12 | Disinhibition (HP:0000734) | 3.47596203 |
13 | Hematochezia (HP:0002573) | 3.40410295 |
14 | Glomerulonephritis (HP:0000099) | 3.32767023 |
15 | Cerebral aneurysm (HP:0004944) | 3.27963287 |
16 | Abnormality of macrophages (HP:0004311) | 3.17047511 |
17 | Keratoconjunctivitis sicca (HP:0001097) | 3.13856039 |
18 | Gingivitis (HP:0000230) | 3.13523232 |
19 | Gastrointestinal infarctions (HP:0005244) | 3.07042125 |
20 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.05488911 |
21 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.05474754 |
22 | Autoimmune thrombocytopenia (HP:0001973) | 3.04066944 |
23 | Amyloidosis (HP:0011034) | 3.02820365 |
24 | Increased IgE level (HP:0003212) | 3.00307173 |
25 | Dysostosis multiplex (HP:0000943) | 2.93669485 |
26 | Mediastinal lymphadenopathy (HP:0100721) | 2.85148895 |
27 | Meningitis (HP:0001287) | 2.84236299 |
28 | Asymmetric septal hypertrophy (HP:0001670) | 2.81192246 |
29 | Keratoconjunctivitis (HP:0001096) | 2.80772826 |
30 | Prolonged bleeding time (HP:0003010) | 2.63582901 |
31 | Episodic fever (HP:0001954) | 2.62943522 |
32 | Arterial tortuosity (HP:0005116) | 2.61282804 |
33 | Interstitial pulmonary disease (HP:0006530) | 2.56247873 |
34 | Nephritis (HP:0000123) | 2.55829081 |
35 | Abnormality of the fingertips (HP:0001211) | 2.54805905 |
36 | Vacuolated lymphocytes (HP:0001922) | 2.54683447 |
37 | Recurrent skin infections (HP:0001581) | 2.51400005 |
38 | Aortic aneurysm (HP:0004942) | 2.49680072 |
39 | Mutism (HP:0002300) | 2.48573919 |
40 | Myositis (HP:0100614) | 2.48454391 |
41 | Periodontitis (HP:0000704) | 2.46251507 |
42 | Obstructive sleep apnea (HP:0002870) | 2.45485184 |
43 | Neurofibrillary tangles (HP:0002185) | 2.43949700 |
44 | Cellulitis (HP:0100658) | 2.42241962 |
45 | Apathy (HP:0000741) | 2.40423442 |
46 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.39886898 |
47 | Mucopolysacchariduria (HP:0008155) | 2.39886898 |
48 | Axonal loss (HP:0003447) | 2.39052281 |
49 | Urticaria (HP:0001025) | 2.38862124 |
50 | Recurrent cutaneous fungal infections (HP:0011370) | 2.38037858 |
51 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.38037858 |
52 | Orchitis (HP:0100796) | 2.37663829 |
53 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.36436828 |
54 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.36436828 |
55 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.36436828 |
56 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.36078417 |
57 | Encephalitis (HP:0002383) | 2.34154541 |
58 | Obstructive lung disease (HP:0006536) | 2.32919652 |
59 | Chronic obstructive pulmonary disease (HP:0006510) | 2.32919652 |
60 | Vascular tortuosity (HP:0004948) | 2.31927731 |
61 | Tetraparesis (HP:0002273) | 2.31682663 |
62 | Supranuclear gaze palsy (HP:0000605) | 2.31628531 |
63 | Peritonitis (HP:0002586) | 2.30968290 |
64 | Diminished motivation (HP:0000745) | 2.28078481 |
65 | Prostate neoplasm (HP:0100787) | 2.27709469 |
66 | Recurrent fungal infections (HP:0002841) | 2.25203450 |
67 | Myocardial infarction (HP:0001658) | 2.23019861 |
68 | Gingival bleeding (HP:0000225) | 2.22686687 |
69 | Pulmonary embolism (HP:0002204) | 2.22405484 |
70 | Spontaneous hematomas (HP:0007420) | 2.21704265 |
71 | Colitis (HP:0002583) | 2.21298624 |
72 | Leukocytosis (HP:0001974) | 2.19040451 |
73 | Slow saccadic eye movements (HP:0000514) | 2.18340008 |
74 | Loss of speech (HP:0002371) | 2.16028248 |
75 | Inflammation of the large intestine (HP:0002037) | 2.13727117 |
76 | Epistaxis (HP:0000421) | 2.12993450 |
77 | Vertigo (HP:0002321) | 2.11763776 |
78 | Striae distensae (HP:0001065) | 2.10988264 |
79 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.10821754 |
80 | Osteolytic defects of the hand bones (HP:0009699) | 2.10821754 |
81 | Hypochromic microcytic anemia (HP:0004840) | 2.09985386 |
82 | Peripheral hypomyelination (HP:0007182) | 2.07075565 |
83 | Gastrointestinal inflammation (HP:0004386) | 2.06942229 |
84 | Arterial thrombosis (HP:0004420) | 2.04518938 |
85 | Papilledema (HP:0001085) | 2.04456636 |
86 | Optic neuritis (HP:0100653) | 2.03883768 |
87 | Retrobulbar optic neuritis (HP:0100654) | 2.03883768 |
88 | Facial diplegia (HP:0001349) | 2.03762302 |
89 | Inappropriate behavior (HP:0000719) | 2.03564829 |
90 | Bone pain (HP:0002653) | 2.03406843 |
91 | Difficulty running (HP:0009046) | 2.01360841 |
92 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.00912463 |
93 | Osteomyelitis (HP:0002754) | 2.00572489 |
94 | Aortic dissection (HP:0002647) | 1.99883669 |
95 | Abnormality of the endocardium (HP:0004306) | 1.98712142 |
96 | Aneurysm (HP:0002617) | 1.96744318 |
97 | Deformed sella turcica (HP:0002681) | 1.95109036 |
98 | Lymphangioma (HP:0100764) | 1.94600220 |
99 | Diplopia (HP:0000651) | 1.93837077 |
100 | Abnormality of binocular vision (HP:0011514) | 1.93837077 |
101 | Abnormality of the peritoneum (HP:0002585) | 1.91644713 |
102 | Pulmonary infiltrates (HP:0002113) | 1.90089801 |
103 | Thick nail (HP:0001805) | 1.89893558 |
104 | Cerebral inclusion bodies (HP:0100314) | 1.89749158 |
105 | Thoracic kyphosis (HP:0002942) | 1.89079993 |
106 | Onion bulb formation (HP:0003383) | 1.88273532 |
107 | Acne (HP:0001061) | 1.88270007 |
108 | Persistence of primary teeth (HP:0006335) | 1.88114676 |
109 | Postural instability (HP:0002172) | 1.87760221 |
110 | J-shaped sella turcica (HP:0002680) | 1.87594825 |
111 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.87532888 |
112 | Chest pain (HP:0100749) | 1.86247103 |
113 | Frequent falls (HP:0002359) | 1.85656495 |
114 | Progressive visual loss (HP:0000529) | 1.85635510 |
115 | Vasculitis (HP:0002633) | 1.85222533 |
116 | Hypochromic anemia (HP:0001931) | 1.84422626 |
117 | Sepsis (HP:0100806) | 1.84359651 |
118 | Vertebral compression fractures (HP:0002953) | 1.83536328 |
119 | Spondylolisthesis (HP:0003302) | 1.83031808 |
120 | Pulmonary artery stenosis (HP:0004415) | 1.82482225 |
121 | Absent frontal sinuses (HP:0002688) | 1.81458631 |
122 | Granulocytopenia (HP:0001913) | 1.80642952 |
123 | Decreased motor nerve conduction velocity (HP:0003431) | 1.79472617 |
124 | Cortical dysplasia (HP:0002539) | 1.77796160 |
125 | Gangrene (HP:0100758) | 1.77467440 |
126 | Enlarged penis (HP:0000040) | 1.76884416 |
127 | Hemiplegia (HP:0002301) | 1.75034795 |
128 | Subacute progressive viral hepatitis (HP:0006572) | 1.74699897 |
129 | Mesangial abnormality (HP:0001966) | 1.73689823 |
130 | Fatigue (HP:0012378) | 1.73638899 |
131 | T lymphocytopenia (HP:0005403) | 1.73229747 |
132 | Petechiae (HP:0000967) | 1.72498773 |
133 | Metaphyseal cupping (HP:0003021) | 1.71877595 |
134 | Basal ganglia calcification (HP:0002135) | 1.70683955 |
135 | Retinal atrophy (HP:0001105) | 1.70471264 |
136 | Increased CSF protein (HP:0002922) | 1.70069407 |
137 | Polygenic inheritance (HP:0010982) | 1.70062474 |
138 | Anorexia (HP:0002039) | 1.69658541 |
139 | Hypergammaglobulinemia (HP:0010702) | 1.69205787 |
140 | Abnormality of the pleura (HP:0002103) | 1.68298462 |
141 | Polycythemia (HP:0001901) | 1.67807338 |
142 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.66161291 |
143 | Neuronal loss in central nervous system (HP:0002529) | 1.66007001 |
144 | Recurrent viral infections (HP:0004429) | 1.64354491 |
145 | Abnormality of the lumbar spine (HP:0100712) | 1.64329893 |
146 | Coarse hair (HP:0002208) | 1.63979340 |
147 | Macroorchidism (HP:0000053) | 1.63809540 |
148 | Impaired platelet aggregation (HP:0003540) | 1.63072529 |
149 | Abnormal platelet function (HP:0011869) | 1.63072529 |
150 | Exotropia (HP:0000577) | 1.62868431 |
151 | Hemoptysis (HP:0002105) | 1.62323960 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PRPF4B | 3.24162325 |
2 | TGFBR2 | 3.01969191 |
3 | TBK1 | 2.71048628 |
4 | RIPK4 | 2.62383668 |
5 | SIK3 | 2.46543899 |
6 | TAOK3 | 2.38567267 |
7 | IRAK4 | 2.31618255 |
8 | TRIB3 | 2.28714913 |
9 | TYK2 | 2.23724695 |
10 | SIK2 | 2.19858294 |
11 | MAP2K3 | 2.15648587 |
12 | CAMK1G | 2.11246712 |
13 | CAMK1D | 2.09325881 |
14 | ERN1 | 2.06772223 |
15 | BLK | 2.03714480 |
16 | MAP3K14 | 2.00885279 |
17 | RIPK1 | 1.98471727 |
18 | TTN | 1.87891818 |
19 | JAK1 | 1.87332571 |
20 | KIT | 1.84610952 |
21 | DMPK | 1.71331229 |
22 | MAP3K9 | 1.67390723 |
23 | EPHB1 | 1.66832245 |
24 | MARK2 | 1.65686847 |
25 | PKN2 | 1.60805266 |
26 | FGFR3 | 1.56061369 |
27 | TNK2 | 1.50105278 |
28 | GRK7 | 1.47303472 |
29 | TAOK1 | 1.42786282 |
30 | PDGFRA | 1.35396279 |
31 | IKBKE | 1.33781217 |
32 | MAP3K3 | 1.29119018 |
33 | EPHA3 | 1.28271976 |
34 | BMPR2 | 1.26753397 |
35 | FGFR4 | 1.24795726 |
36 | CDK12 | 1.24732391 |
37 | GRK6 | 1.24522986 |
38 | * ZAP70 | 1.24476084 |
39 | HCK | 1.24131127 |
40 | MARK1 | 1.21395549 |
41 | EPHB2 | 1.20320359 |
42 | NEK9 | 1.19172715 |
43 | MAP3K2 | 1.15819343 |
44 | MAP3K12 | 1.13273002 |
45 | NTRK3 | 1.13219878 |
46 | RET | 1.12497091 |
47 | JAK3 | 1.11797624 |
48 | MATK | 1.10783793 |
49 | PTK6 | 1.10486273 |
50 | MAPK12 | 1.09765938 |
51 | CHUK | 1.08802456 |
52 | CSF1R | 1.08331815 |
53 | IKBKB | 1.06059001 |
54 | CDC42BPA | 1.05627057 |
55 | FES | 1.02987499 |
56 | SYK | 1.02317388 |
57 | MAP4K1 | 1.02297503 |
58 | RPS6KA2 | 1.00274549 |
59 | MAP3K11 | 0.97575898 |
60 | TAOK2 | 0.95235779 |
61 | CSK | 0.93360872 |
62 | MAP3K7 | 0.92832642 |
63 | MARK3 | 0.90099832 |
64 | PDK1 | 0.89907810 |
65 | LMTK2 | 0.89383277 |
66 | SCYL2 | 0.87441472 |
67 | NTRK2 | 0.86904359 |
68 | DAPK2 | 0.86734088 |
69 | KSR1 | 0.86552031 |
70 | PDGFRB | 0.86551654 |
71 | YES1 | 0.85834367 |
72 | PTK2B | 0.84824455 |
73 | SGK2 | 0.84743634 |
74 | MAP3K13 | 0.84318989 |
75 | MAP3K10 | 0.83569992 |
76 | BMX | 0.83077850 |
77 | ICK | 0.79835619 |
78 | MYLK | 0.79215883 |
79 | MAPK7 | 0.77989626 |
80 | ERBB3 | 0.77333474 |
81 | EGFR | 0.75550455 |
82 | IRAK3 | 0.75408896 |
83 | * JAK2 | 0.74475929 |
84 | TXK | 0.74172952 |
85 | PAK4 | 0.73432587 |
86 | PRKD2 | 0.72184277 |
87 | STK11 | 0.70830999 |
88 | SGK3 | 0.69741554 |
89 | IRAK1 | 0.66659633 |
90 | TYRO3 | 0.65664752 |
91 | HIPK2 | 0.65033151 |
92 | MOS | 0.65033040 |
93 | TIE1 | 0.62765757 |
94 | NTRK1 | 0.62365486 |
95 | FGR | 0.60012535 |
96 | MAP3K1 | 0.59449276 |
97 | CAMKK1 | 0.59400292 |
98 | TESK1 | 0.59273063 |
99 | SGK494 | 0.58919707 |
100 | SGK223 | 0.58919707 |
101 | IRAK2 | 0.58478032 |
102 | FYN | 0.55785675 |
103 | MAP3K5 | 0.55703095 |
104 | MAP3K6 | 0.55154278 |
105 | DYRK1B | 0.55070994 |
106 | RAF1 | 0.54922879 |
107 | PRKCH | 0.54661004 |
108 | SIK1 | 0.54634784 |
109 | LRRK2 | 0.54531105 |
110 | CAMK4 | 0.53846946 |
111 | LYN | 0.53798628 |
112 | CDK6 | 0.52558845 |
113 | MINK1 | 0.52109177 |
114 | FGFR2 | 0.51398503 |
115 | PHKG2 | 0.51274673 |
116 | PHKG1 | 0.51274673 |
117 | PIM2 | 0.50768752 |
118 | STK3 | 0.50488260 |
119 | CLK1 | 0.50447275 |
120 | STK38 | 0.49725132 |
121 | PAK2 | 0.48692264 |
122 | RPS6KC1 | 0.48255345 |
123 | RPS6KL1 | 0.48255345 |
124 | ABL1 | 0.47543138 |
125 | KSR2 | 0.47376790 |
126 | BTK | 0.46701121 |
127 | TRPM7 | 0.45882282 |
128 | LCK | 0.45873055 |
129 | MAP2K4 | 0.45578392 |
130 | MAPKAPK2 | 0.44625817 |
131 | PIK3CG | 0.44419114 |
132 | ITK | 0.43970194 |
133 | ABL2 | 0.43572438 |
134 | PDPK1 | 0.42113211 |
135 | EEF2K | 0.41419153 |
136 | WNK1 | 0.41121309 |
137 | RPS6KA6 | 0.39007568 |
138 | ERBB2 | 0.38939078 |
139 | GSK3A | 0.38887155 |
140 | PDK2 | 0.38503741 |
141 | PRKD1 | 0.37891068 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.29739182 |
2 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.11133913 |
3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.99213980 |
4 | Lysosome_Homo sapiens_hsa04142 | 1.74519577 |
5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.74325747 |
6 | Pertussis_Homo sapiens_hsa05133 | 1.73524393 |
7 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.73018455 |
8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.72404630 |
9 | Tuberculosis_Homo sapiens_hsa05152 | 1.65831776 |
10 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.57787843 |
11 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.53367400 |
12 | Viral myocarditis_Homo sapiens_hsa05416 | 1.50733558 |
13 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.50498430 |
14 | Phagosome_Homo sapiens_hsa04145 | 1.44180828 |
15 | Salmonella infection_Homo sapiens_hsa05132 | 1.44108051 |
16 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.42268230 |
17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.41163438 |
18 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.40435114 |
19 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.37817712 |
20 | Malaria_Homo sapiens_hsa05144 | 1.36899623 |
21 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.27055458 |
22 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.27040444 |
23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.26785421 |
24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.25372434 |
25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.24564803 |
26 | Influenza A_Homo sapiens_hsa05164 | 1.23127575 |
27 | Legionellosis_Homo sapiens_hsa05134 | 1.22643939 |
28 | Amoebiasis_Homo sapiens_hsa05146 | 1.20380241 |
29 | * Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.19768517 |
30 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.19671020 |
31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.19431546 |
32 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.19139172 |
33 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.18760227 |
34 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.15921543 |
35 | Measles_Homo sapiens_hsa05162 | 1.15540694 |
36 | Shigellosis_Homo sapiens_hsa05131 | 1.11328333 |
37 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.10177529 |
38 | Platelet activation_Homo sapiens_hsa04611 | 1.07950359 |
39 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.05252319 |
40 | Apoptosis_Homo sapiens_hsa04210 | 1.04660632 |
41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.02254330 |
42 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.00699338 |
43 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.00538240 |
44 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.00312797 |
45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.99564060 |
46 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.99159194 |
47 | Asthma_Homo sapiens_hsa05310 | 0.97636655 |
48 | Focal adhesion_Homo sapiens_hsa04510 | 0.96900934 |
49 | Glioma_Homo sapiens_hsa05214 | 0.96592110 |
50 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.96034376 |
51 | Long-term potentiation_Homo sapiens_hsa04720 | 0.95731107 |
52 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.94344397 |
53 | Hepatitis B_Homo sapiens_hsa05161 | 0.94075629 |
54 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.93555095 |
55 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.92752057 |
56 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.92489538 |
57 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.92352634 |
58 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.90496927 |
59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.90207082 |
60 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.89135921 |
61 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.88387564 |
62 | Endocytosis_Homo sapiens_hsa04144 | 0.88147022 |
63 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.86730010 |
64 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.86643922 |
65 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.86230560 |
66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.85746430 |
67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85486649 |
68 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.84438541 |
69 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.84356068 |
70 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.83600895 |
71 | Allograft rejection_Homo sapiens_hsa05330 | 0.81109461 |
72 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.79213967 |
73 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.78779645 |
74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.77073288 |
75 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.76445475 |
76 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.74880952 |
77 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.74879951 |
78 | Insulin resistance_Homo sapiens_hsa04931 | 0.74682168 |
79 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.74089395 |
80 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.74048932 |
81 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.73839516 |
82 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.73838542 |
83 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.73176318 |
84 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.72873061 |
85 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.72576820 |
86 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.72359828 |
87 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.69216107 |
88 | Hepatitis C_Homo sapiens_hsa05160 | 0.69018078 |
89 | Colorectal cancer_Homo sapiens_hsa05210 | 0.68350904 |
90 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.68221915 |
91 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.67704100 |
92 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67555163 |
93 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67426838 |
94 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.67315540 |
95 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.67195505 |
96 | Adherens junction_Homo sapiens_hsa04520 | 0.66078030 |
97 | Renin secretion_Homo sapiens_hsa04924 | 0.64201235 |
98 | Prion diseases_Homo sapiens_hsa05020 | 0.63101628 |
99 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.62928612 |
100 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.62898573 |
101 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.62377832 |
102 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.61388537 |
103 | Endometrial cancer_Homo sapiens_hsa05213 | 0.60763580 |
104 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.60471070 |
105 | Long-term depression_Homo sapiens_hsa04730 | 0.60291480 |
106 | Prostate cancer_Homo sapiens_hsa05215 | 0.59791797 |
107 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.59510459 |
108 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58405089 |
109 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58170338 |
110 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.57764069 |
111 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57671108 |
112 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.57423936 |
113 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55210370 |
114 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.54592176 |
115 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.53586525 |
116 | * Ras signaling pathway_Homo sapiens_hsa04014 | 0.52381696 |
117 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52105792 |